UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
92 hedge funds and large institutions have $122M invested in Unity Biotechnology in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 27 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.24% less ownership
Funds ownership: 3.95% → 3.71% (-0.24%)
26% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 27
Holders
92
Holding in Top 10
3
Calls
$1.03M
Puts
$761K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$727K | |
| 3 | +$709K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$521K |
| 5 |
Two Sigma Advisers
New York
|
+$398K |
Top Sellers
| 1 | -$2.81M | |
| 2 | -$1.37M | |
| 3 | -$865K | |
| 4 |
Jane Street
New York
|
-$539K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$478K |